Find Clinical Trial
Exploratory bioavailability of two formulations of gliclazide MR tablets 120 mg (I.R.I.S.) in healthy volunteers under fed and fasting conditions
← Back
| Study Phase |
Phase 1 |
| Therapeutic Area |
Metabolism |
| Indication | Diabetes - Type II |
| Sponsor | Institut de Recherches Internationales Servier (I.R.I.S) |
| Active substance/ Medical device |
GLICLAZIDE |
| Active Substance Code | S005190 |
| Protocol Code | S005190-170 |
| Eu CT | 2023-507802-15-00 |
Documents and links
| Results are not yet available. |
Servier Glossary of Terms
To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.
© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility
